Literature DB >> 31313366

Letter: immunogenicity of anti-TNF in elderly IBD patients-authors' reply.

Siddharth Singh1,2, Vipul Jairath3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31313366      PMCID： PMC6640851          DOI： 10.1111/apt.15379

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN： 0269-2813            Impact factor:   8.171


× No keyword cloud information.
  3 in total

1.  Early combined immunosuppression may be effective and safe in older patients with Crohn's disease: post hoc analysis of REACT.

Authors:  Siddharth Singh; Larry W Stitt; Guangyong Zou; Reena Khanna; Parambir S Dulai; William J Sandborn; Brian G Feagan; Vipul Jairath
Journal:  Aliment Pharmacol Ther       Date:  2019-03-19       Impact factor: 8.171

2.  Older age is associated with higher rate of discontinuation of anti-TNF therapy in patients with inflammatory bowel disease.

Authors:  Amit Desai; Zachary A Zator; Punyanganie de Silva; Deanna D Nguyen; Joshua Korzenik; Vijay Yajnik; Ashwin N Ananthakrishnan
Journal:  Inflamm Bowel Dis       Date:  2013-02       Impact factor: 5.325

3.  Efficacy and safety of anti-TNF therapy in elderly patients with inflammatory bowel disease.

Authors:  T Lobatón; M Ferrante; P Rutgeerts; V Ballet; G Van Assche; S Vermeire
Journal:  Aliment Pharmacol Ther       Date:  2015-06-24       Impact factor: 8.171
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.